Examines drug release profiles in nanofibers for diabetes, suggesting potential treatment benefits.
Respective vanadium compounds with bidentate benzimidazole chelators were incorporated into biodegradable electrospun nanofibers (ENFs). The resultant nanocomposites illustrated time-dependent drug release profiles and glucose-lowering activities.
No takes yet. Share an insight, caveat, or question.
Maikoo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: